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Abstract
Background: Data from Egyptian studies provide widely varying estimates on the prevalence of pre-
malignant and malignant cervical abnormalities and human papilloma virus (HPVs) infection. To define the
prevalence and risk factors of pre-invasive and invasive cervical cancer (cacx), a community based full-scale
cross sectional, household survey including 5453 women aged between 35 and 60 years was conducted.
Methods: The study period was between February 2000 and December 2002. Initially, conventional
Papanicolaou (Pap) smears were evaluated using the Bethesda system (TBS), followed by colposcopic
guided biopsy (CGB) for all epithelial abnormalities (EA). In a third step, HPV was tested on all EA by in-
situ hybridization (ISH) using first the broad spectrum HPV probe recognizing HPVs 6, 11, 16, 18, 30, 31,
35, 45, 51 and 52 followed by subtyping with probes 6/11, 16/18 and 31/33. Lastly, unequivocal cases were
immunostained for herpes simplex type-2 (HSV-2), cytomegalovirus (CMV), and human immunodeficiency
virus (HIV).
Results: EA representing 7.8% (424/5453), were categorized into atypical squamous cell of undetermined
significance (ASCUS) (34.4%), atypical glandular cell of undetermined significance (AGCUS) (15.3%),
combined ASCUS and AGCUS (3.1%), low grade squamous intraepithelial lesions (SIL) (41.0%), high grade
SIL (5.2%) and invasive lesions (1%). CGB of EA (n = 281) showed non neoplastic lesions (12.8%), atypical
squamous metaplasia (ASM) (19.2%), cervical intraepithelial neoplasia I (CIN) (44.4%), CIN II (4.4%), CINIII
(2.8%), endocervical lesions (5.2%), combined squamous and endocervical lesions (10.0%), invasive
squamous cell carcinoma (SCC) (0.02%) and extranodal marginal zone B cell lymphoma (MZBCL) (0.02%).
The overall predictive value of cytology was 87% while the predictive value for high grade lesions was 80%.
On histological basis, HPVs were present in 94.3% of squamous lesions while it was difficult to be identified
in endocervical ones. ISH revealed positivity for pan HPV in 65.9% of the studied biopsies (n = 217), with
incorporation of the viral genome HPV 6/11, 16/18 and 31/33 in 11.1%, 33.3% and 17.1% respectively.
Multiple HPVs infections were identified in 0.02%.
Conclusion: Pre-invasive high grade lesions and invasive cervical carcinoma represent 0.5% and 0.04%
respectively in Egyptian women. HPV mostly 16/18 as a risk factor (p < 0.001), was frequently associated
with mixed infections (p < 0.001) and bilharzial infestation (p < 0.001).
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Background
In developed countries, with effective and extensive
screening with Pap smears, it is usually possible to iden-
tify and treat asymptomatic precursor lesions of cacx,
making it nearly 100% preventable [1]. However, five out
of six women with cacx live in developing countries, and
80% of them are diagnosed at advanced stages [2]. Data
from Egyptian studies provide widely varying estimates
on the prevalence of pre-invasive cervical lesions ranging
from 1% [3] to 8% [4] with an age range from 20–60
years. Invasive lesions represented 59.58% of all female
genital tract malignancy according to Egyptian National
Cancer Institute data [5]. A recent monograph from the
Egyptian National Cancer Registry of seven cancer centres
of the Ministry of Health and Population, reported an
incidence rate for all ages ranging from 0.12% to 0.77%
depending on geographical regions, being more prevalent
in Lower Egypt [6]. To be stressed here, that most patients
presented at late incurable clinical stages [7,8]. Previous
small hospital based series confirmed the incorporation
of HPV genome in invasive lesions [8,9]. In addition,
schistosomiaisis [8,10], and Chlamydia trachomatis
(Chlamydia T) [11], has been found to be risk factors in
Egyptian studies.
In the present work we looked for HPV and other risk fac-
tors [12-17] in the Egyptian population. These include
viruses such as HSV-2 [16,18], CMV [16], and HIV
[17,19]. Sexual activity with multiple sexual partners, sex
with a promiscuous partner, history of sexually transmit-
ted infections, sexual intercourse at a young age [20-22],
bacterial vaginosis [23], Chlamydia T [11,24], schisto-
somiaisis [8,10,25], poor socioeconomic and low educa-
tional status [26-29], risky jobs [30] and poor nutritional
status [31] have also been implicated as risk factors.
This study was the first one to be conducted in Egypt at a
National level as community based full-scale cross sec-
tional survey. The main objective was to assess the preva-
lence of pre-invasive and invasive cacx among Egyptian
women aged between 35 and 60 years. Specifically it
aimed at assessing the prevalence of biopsy-confirmed
squamous, endocervical lesions and invasive cancer, iden-
tifying the preventable risk factors and exploring the
knowledge and practices of the target population toward
cacx screening. Therefore representative data on this prob-
lem should permit better evaluation of possible alterna-
tive approaches for the design of a national cacx
prevention program.
Methods
Duration of the study
The protocol was set up and approved by the funding
agency "United States Agency for International Develop-
ment (USAID) in January 2000. The field work started July
2000 and terminated in December 2002.
Sampling
Sampling design and target population
The prevalence rates used for sample size calculations
were chosen based on available data from Egyptian stud-
ies and results of recent computer modelling. A computer
simulation model of incidence of cacx, based on a low risk
population in the United States, suggested that the preva-
lence of SIL, in a previously unscreened population would
be 2–3% among women 35 years old and above. The sam-
ple size estimates assume simple random sampling equal
to 3012 eligible women. Assuming a design effect of 2 due
to cluster sampling, the sample size needs to be doubled
to be 6000. The target population was ever-married
women aged 35 to 60 years. Women who were pregnant
or menstruating at time of tests were excluded.
Selection of study population
A multi-stage sampling process was used, based on a sam-
pling frame from the Egypt Demographic Health Survey
(DHS) 2000 [32]. A sample of different regions of Egypt
was made using data from the Human Development
Index, which is a composite index of education, health
status and living standard. Ten out of twenty six governo-
rates were randomly chosen for the survey, representing
urban/rural regions including Lower Egypt (LE), Upper
Egypt (UE) and Urban governorates. From each of the
sample governorates, 60 clusters of 230 households were
selected that were expected to include 125 eligible
women. Allowing for refusals would give about 100
women per cluster.
Ethical considerations
The study protocol was approved by the Ministry of
Health and Population Ethical Review Board. All women
were informed about the procedures of the study, the pos-
sibility of abnormalities being found, including cacx and
that further invasive procedures may be necessary. Con-
sents were obtained from the women before participation.
Data collection
Questionnaire
A total of 153 questions collected data about women's
background and relevant risk factors including 1- socioe-
conomic and general characteristics of women and their
husbands, living conditions, lifestyle, marital status, men-
strual and obstetric history and use of family planning, 2-
current general health problems with special emphasis on
schistosomiaisis, 3- gynecological health problems
including personal and family history of cacx or other can-
cers and women and husbands' history of genital tract
infections.Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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Clinical and gynecological examinations
General clinical examinations and urine laboratory test
for schistosomiasis by spotting positive ova were carried
out. Problems such as cystocoele, rectocoele, adnexal ten-
derness, or masses, uterine prolapse, cervical polyps, warts
and cervical discharge, were noted and evaluated. Pap
smears were taken.
Pathological study
Cytopathological examination
Samples from the ectocervix and endocervix were col-
lected using Ayer's spatula and endocervical brush and
fixed onto labelled glass slides with cytospray. The cells
were classified according to TBS 1991 [33]. Strict criteria
were used to qualify a lesion as HPV related [34], ASCUS
[34,35], AGCUS [36], EGD [37] and to discriminate
AGCUS from neoplastic endocervical cells [38] (table 1).
Colposcopic-guided biopsy and Histopathology
All EA were biopsied in an attempt to evaluate the preva-
lence of low/high grade dysplastic changes and invasive
lesions. The received biopsies were left for 24 hours in
neutral buffered formalin. Tissue embedding and process-
ing were followed by hematoxylin and eosin (H&E) stain-
ing. The presence of bilharzial infestation was evaluated
in tissue sections. Serial sections from each biopsy were
classified according to the World Health Organization
(WHO) for cervical neoplasia [39]. Here also strict criteria
were used for histopathologic evaluation. To qualify a
lesion as HPV-related, a scoring system was used for which
a minimum of 6 points out of 10 were needed [34]. Data
not fulfilling these criteria were classified as ASM (table
1).
In situ hybridization for HPVs
ISH for HPVs was effectuated for epithelial lesions starting
from ASM. The materials used are summarized in table 2.
Initially, HPVs were screened with the wide spectrum HPV
probe recognizing genomic DNAs of HPV types 6, 11, 16,
18, 30, 31, 31, 33, 35, 45, 51 and 52. Further subtyping
with HPV 6/11, 16/18 and 31/33 were performed for
cases positive for pan HPV and cases negative/unsatisfac-
tory for pan HPV but with frank HPV related lesions on
conventional H&E biopsies. Positive control tissues
infected with HPV were included in every ISH procedure
and the technique was evaluated according to the result of
this positive control. The steps for ISH are followed
according to the manufacturer instructions. In brief, fol-
lowing deparaffinization, tissue digestion with 250–500
μl of pepsin HCl, were applied to tissue sections and the
latter were incubated in 37°C oven for 10 minutes, fol-
lowed by slides wash in distilled water. Denaturation and
hybridization started by applying enough drops of the
probe to tissue sections, coverslipping, laying the slide on
pre-warmed slide warmer, and incubation in 37°C oven
for 60 minutes. Slides were immersed in Tris buffer to
remove covers, washed and immersed in warm stringent
wash, incubated in 37°C oven for 30 minutes, and then
washed in Tris buffer. For revelation, streptavidin alkaline
phosphatase was applied to sections for 20 minutes.
Slides were washed in Tris buffer twice. BCIP/NBT were
applied to sections and incubated in dark for 60 minutes,
followed by wash in Tris buffer twice. Slides were lastly
washed distilled water and mounted using aqueous
media. Positive signals were seen as dark blue dots in the
affected nuclei.
Immunohistochemistry
Immunohistochemistry (IHC) was effectuated for equivo-
cal cases negative for HPV and cases with histological sus-
picion for infections with HSV-2 or CMV. In these
instances, HSV-2, early and late CMV antigens were
assessed. For other viral lesions not proven cytologically,
histologically or by IHC to be HSV-2 or CMV infection,
p24 capsid proteins for HIV was used. In addition, cytok-
eratin, leucocyte common antigen and CD79a were used
to diagnose an extranodal MZBCL. The materials used are
summarized in table 2. The steps of IHC are followed
according to the manufacturer instructions. All incuba-
tions were performed at room temperature. Tris buffer
was used for washing. In brief, following deparaffiniza-
tion, the endogenous peroxidase activity was quenched by
0.3% hydrogen peroxide for 5 minutes followed by wash-
ing. Primary antibodies diluted at 1/50, were incubated
for 30 minutes, then slides were rinsed in successive buffer
bathes. The revelation was done with LSAB-2 detection
kit. Finally, diaminobenzidine tetrachloride (DAB) was
applied for 5 minutes. Slides were counterstained in Har-
ris haematoxylin (Hx), dehydrated, cleared in xylene and
coverslipped. Tissues infected with HSV-2, CMV and p24
were used as positive control while replacement of the
antibodies by Tris buffer was used as negative control for
the procedure. IHC results were evaluated either as posi-
tive or negative.
Statistical analysis
Lesions were grouped according to histological results
into: 1- normal without epithelial changes, 2- ASM, 3- low
grade lesions including CINI with or without HPV and
EGD alone or combined with either ASM or CINI, 4- High
grade lesions including CINII, CINIII/CIS alone or com-
bined with EGD and adenocarcinoma in situ (AIS), and 5-
Invasive lesions. A cut-off point of 45 years was used to
categorize two aged groups 35–45 and >45–60 years. SPSS
version 9 was used for statistical analysis. Descriptive
analysis was made of demographic, cytology and follow
up CGB data. Cross tabulations with significance tests and
Odd Ratio (OR) with 95% confidence interval (CI) were
made. Multivariate analysis was carried out to estimateInfectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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the main determinant risk factors for cacx in the study
population.
Quality control
A pilot study was carried out to test methods of obtaining
community cooperation and reactions of respondents to
the research procedures and their desire to participate. All
staff members were trained to ensure standardization of
methods. A written operational manual explaining in
details how to perform Pap smear and CGB and all stain-
ing steps was prepared. Random re-screening of 20% of
the Pap smear and all EA was done for every cluster, in
addition to the strict criteria used for evaluating abnormal
lesions and was assessed by kappa test.
Results
History cervical cancer and awareness of the risk factors
Twelve women (0.2%) had a female relative diagnosed as
cacx. Less than 2%, mostly from urban areas, had ever had
Pap smear with normal results in 77% of them. Only three
women mentioned having dysplastic/atypical changes
before, however these finding were not documented by
cytopathological reports and their Pap smears were nor-
mal in the present study. Only 2% could identify smok-
ing, hormones, and infection as risk factors but not HPV.
Cytopathology
The total number of Pap smears studied was 5658. How-
ever, 5453 women with complete data were included in
Table 1: Cytological and histological criteria used for diagnosis of cervical lesions
Lesions Criteria for diagnosis Ref.
Cytologic HPV Koilocytic atypia
Multinucleation (frequently binucleation)
Dyskeratosis
Parakeratosis
34
ASCUS Nuclear enlargement approximately twice the size of an immature squamous metaplastic cell
Slight increase in nucleo-cytoplasmic ratio
Nuclear chromatin clumping
Variation in nuclear size and shape including mild hyperchromasia, binucleation, and mild irregularity in the nuclear 
membranes
35, 36
AGCUS Nuclear enlargement approximately twice the size of an endocervical cell.
Nuclear pseudostratification
Mild hyperchromasia
37
Discriminating AGUS from neoplastic 
endocervical cells
Presence of normal ECCs, singly or in sheets
Absence of necrosis
Absence of papillary groups
Mild anisonucleosis
Marked chromatin distribution
37
EGD Nuclei not cytologically malignant
Nuclear hyperchromasia and pseudostratification
Low mitotic figures
Absence of papillary formation and cribriform pattern
38
Histologic HPV Koilocytic atypia: 4 points
Binucleation: 2 points
Dyskeratosis: one point
Basal cell hyperplasia: one point
Papillomatosis: one point
Acanthosis: one point
34
Table 2: Reagents used in the study
Reagents Source code
ISH detection kits and probes
ISH detection system Dako K0601
Wide spectrum HPV Dako Y1404
6/11 HPV Dako Y1411
16/18 HPV Dako Y1412
31/33 HPV Dako Y1413
IHC detection kits and antibodies
LSAB-2 Detection kit Dako K0680
HSV- 2 Dako B0116
CMV early antigens Novocastra NCL- CMV- EA
CMV late antigens Novocastra NCL- CMV- EA
P 24 capsid protein Novocastra NCL-p24Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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the study (97%). Unsatisfactory results were present in
195 smears (3%), mostly due to absence of endocervical/
transformation zone and poor fixation in 66.15% and
16.92% respectively, and were more pronounced in the
first three governorates. Two third of the women had
inflammatory changes (63%), while epithelial abnormal-
ities were identified among 8%.
Inflammatory and Reparative Changes
All the inflammatory smears were associated with repara-
tive changes including reserve cells hyperplasia, early
immature squamous metaplastic cells, cells merging to
maturation and fully mature cells. This process was more
pronounced in association with IUD devices. Three
smears showed mature reparative changes only, probably
representing post inflammatory squamous metaplasia.
The most common infection was bacterial (49%) (figure
1).
Epithelial abnormalities according to TBS
Epithelial changes were found in 424 women (8%), more
commonly among LE women (9%) and less commonly in
rural UE (6%); one-third of these cases were among urban
governorates residents (p < 0.005). The most common
type was LGSIL including HPV infection (41%) (figure 2).
HGSIL was found in 22 women (5%). Cytological features
highly suggestive of invasive carcinoma were diagnosed in
four cases. Table 3 illustrates the EA.
Histological evaluation of CGB
CGB was recommended for all women with EA (424
ones). A total of 281 ones (66%) were available. Unsatis-
factory biopsies were encountered in 30 cases (10.67%);
the most common cause was absence of endocervical tis-
sue in a lesion previously diagnosed as AGCUS (62%),
and was more obvious in earlier governorates. The histo-
logical results are summarized in table 4. The strict criteria
used for evaluating HPVs histologically enabled us to cat-
egorize squamous lesions with or without HPV infection
(table 5). However, there were no valid criteria for identi-
fication of HPVs in endocervical lesions, making ISH a
premium for diagnosis of HPVs infected endocervical
lesions. The overall predictive value of cervical cytology
was 87% with values of 90.10%, 86.68%, 80% and
78.13% for LGSIL, ASCUS, HGSIL and AGCUS respec-
tively. Figures 3, 4 and 5 illustrate cyto-histologic correla-
tion of some cases.
IHC results
Only one case cytologically diagnosed as ASCUS, was pos-
itive for HSV-2. All suspicious cases tested for CMV and
HIV infections were negative by IHC. Accidentally, one
case positive for leukocyte common antigen and CD79a
was classified as extranodal MZBCL.
Inflammatory changes Figure 1
Inflammatory changes.
LGSIL HPV associated Figure 2
LGSIL HPV associated showing koilocytic atypia (A), binucleation (B) and dyskeratosis (C) Papanicolaou stain, × 40.Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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Prevalence of HPV and cervical lesions
ISH using pan HPV probe tested on 217 cases, was posi-
tive among 66%, negative in 29% and non significant in
5% of cases (figures 6, 7 and 8). The prevalence of cervical
lesions in the studied population is summarized in tables
6 while that of HPV in the tested abnormal biopsies is
illustrated in table 7. The viral genome for HPV 6/11, 16/
18 and 31/33 was incorporated in 11.1%, 33.3% and
Table 3: Percentage distribution of women by cytological epithelial abnormalities according to place of residence
Epithelial Urban LE UE P Total
abnormalities governorates Urban Rural Urban Rural Freq. %
Atypical
ASCUS 37.2 27.3 35.2 46.3 26.7 146 34.4
AGCUS 14.9 14.5 16.2 29.3 8.0 65 15.3
Combined 1.4 1.8 4.8 2.4 5.3 13 3.1
<0.05
Squamous lesions
LGSIL 41.2 43.6 37.1 12.2 60.0 174 41.0
HGSIL 4.7 10.9 5.7 7.3 0.0 22 5.2
Invasive
Squamous 0.0 1.8 0.0 2.4 0.0 2 0.5
Endocervical 0.7 0.0 1.0 0.0 0.0 2 0.5
Total 148 55 105 41 75 424
Table 4: Histological results and pan HPV ISH of CGB
Results Histology Pan HPV ISH
Freq. % Negative Positive NS
Normal 32 12.8 ND ND ND
ASM 48 19.2 39 6 3
CIN
CINI 111 44.4 16 89 6
CINII 11 4.4 2 9 0
CINIII/CIS 7 2.8 0 7 0
Glandular lesions
EGD 12 4.8 4 8 0
AIS 2 0.8 0 1 1
Combined dysplasia
ASM + EGD 4 1.6 2 2 0
CINI+EGD 18 7.2 0 17 1
CINII+EGD 2 0.8 0 2 0
CINIII+EGD 1 0.4 0 1 0
Invasive
Invasive carcinoma 1 0.4 0 1 0
Lymphoma 1 0.4 ND ND ND
Total 250 100 63 (29.0%) 143 11
(65.9%) (5.1%)
217 (86.8%)
ND: not done NS: non significantInfectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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17.1% respectively in the studied biopsies (table 8). Inter-
estingly, 12.5% (6/48) of ASM were HPV positive.
Risk factors of cervical lesions
Risk factors of ASM were infection with HPV especially
subtypes 16/18 and 31/33 and ever usage of vaginal con-
traceptives (p <0.0001 for each). The risk factors for low
grade CIN are still menstruating (p <0.001), working (p
<0.0001), HPV infection with the three probes studied 6/
11, 16/18 and 31/33 (p <0.000 for each), while for high
grade CIN infection, with HPV mainly subtypes 16/18
and 31/33 (p <0.001) was the common threat. Multiple
regression analysis revealed that being a working woman
(OR 2.0, 95% CI 1.3–3.1) and still menstruating (OR 1.5,
95% CI 1.1–2.1) were the main risk factors.
HPVs infection were more pronounced in younger age,
actually married, still menstruating and ever used hormo-
nal or vaginal contraceptives (p <0.05 for each), and
unskilled workers (p <0.0001). In addition, there was an
increasing positivity rate for HPV with increasing lesion
severity. Applying multiple regression analysis revealed
that being a working woman (OR 2.0, 95% CI 1.3–3.2),
still menstruating (OR 1.6, 95% CI 1.1–2.3) and women
who ever had hormonal contraception (OR 1.5, 95% CI
1.1–2.1) were the main determinants for HPV infection.
HPV infection seemed to be more among women whose
husbands ever had another wife or travelled before, how-
ever this finding was not statistically significant.
Discussion
HPV has been recognized as the necessary cause of cervical
cancer [2]. However, in the present study, awareness of
HPV as major risk factor for cacx was very low among the
studied population while smoking, hormones, and infec-
tions were identified as main risk factors. Previous studies
approaching this point came out with the same conclu-
sion of ignorance of association between HPV and cacx
[40,41]. As expected, only 1.5% of studied women,
mostly from urban areas, had Pap smear. Three of them
mentioned, without documents, having results consistent
with invasive lesions. However, their cytological results
were normal in this study. This important point highlights
the absence of health culture in the population. Studies
from other countries, reported that only 5% of women in
low and middle income countries received screening, usu-
ally in private clinics and few urban settings, contrary to
high-income countries where up to 70% of women were
screened [1,42].
ASM cases were positive for HPV 16/18 and 31/33. ASM,
a poorly characterized cervical lesion with uncertain bio-
logical and clinical significance, shares some but not all
morphological features of SIL [43,44]. It has been shown
that HPV positive ASM biopsies were significantly more
likely to have concurrent or subsequent diagnosis of HSIL
than HPV negative ones [43,45]. Unfortunately, the actual
study is limited by the fact that it covers a single period
and had no opportunity to follow up ASM HPV positive
cases. The rational for inclusion of ASM was based on the
fact that recent studies found HPVs genome incorporated
in normal squamous epithelium [22,46,47]. However,
due to financial restraints, normal tissues were not
included, to evaluate the presence/absence of HPVs.
This community based study confirms previous hospital
based one reporting low prevalence rate for CIN; analysis
of 4458 patients showed a prevalence of 0.36%, 0.23%
and 0.12% for CINI, CINII and CINII respectively [48]. In
addition, the Middle East Cancer Consortium reported
0.027% prevalence rate for cacx for Egyptian women [49].
The prevalence of EA and HPV infections in Egypt is com-
parable to other geographical areas in Muslim and Middle
East countries. In Saudi Arabia, EA represented 3.14% out
of 3088 screened women with ASCUS, LGSIL, HGSIL,
invasive SCC, AGCUS and adenocarcinoma represented
0.45%, 0.93%, 0.55%, 0.13%, 0.13% and 0.03% respec-
tively [50]. In Jordan a prevalence of 0.026% has been
reported [49]. In Lebanon, a study conducted on 1,026
women revealed a prevalence of 4.9% for HPV with type
16 representing 3% [51]. In Morocco, 70.5% of invasive
carcinoma cases were HPV positive, 34.88% cases had
HPV16, and 15.5% cases had HPV18 [52]. In Iran, contro-
versial data were reported; 73.9% of HPV positive cacx
contained HPV16 [53], while in another study HPV16 was
Table 5: Histological evidence of HPVs infection in neoplastic squamous lesions
Freq. Histologic evidence of HPV %
CIN I 111 104 93.7
CINII 13 12 92.3
CINIII 7 6 85.7
Combined dysplasia 25 25 100.0
Invasive carcinoma 1 1 100.0
Total 157 148 94.3Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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Combined dysplasia, A- ASCUS, the nucleus is twice the size of the left intermediate cell on the right, Pap stain, × 40 Figure 3
Combined dysplasia, A- ASCUS, the nucleus is twice the size of the left intermediate cell on the right, Pap stain, ×40. B- 
Another area showing nuclear pseudostratification and loss of the normal honey combing, Pap stain, ×40. C- A third area 
showing ASCUS and AGCUS in the same field, Pap stain, ×40. D- Glandular colonization by the neoplastic cells and dysplastic 
endocervical lining, H&E, ×10. E- Higher power magnification of the colonized glands showing koilocytes, increased nucleo-
cytoplasmic ratio and large nucleolated nuclei, H&E, ×40. F- Higher power magnification of the endocervical dysplastic cells, 
H&E, ×40. G- Another field showing colonization of the glands by the koilocytes and residual normal endocervical cells, H&E 
staining, ×40. H- Surface epithelium showing koilocytic atypia, acanthosis, papillomatosis and basal cell hyperplasia, H&E, ×40.
A B 
C  D 
E F 
G H Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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identified in 26.7% and none of the samples were positive
for HPV18 [54].
Studies showed significant geographic variation in the
prevalence of oncogenic viral types in cervical lesions with
roughly half of all cacx worldwide containing HPV 16.
Other important high risk types are HPV 18, 45, and 31.
Less prevalent high risk types include HPV 26, 33, 35, 39,
51, 52, 56, 58, 59, 68, 73, and W13b [47]. In Africa, the
most common subtype is HPV 16 followed by 45, 18, 31
and 33 [55], a point concordant with the actual work.
Unskilled workers were at greater risk for HPV infection
and other EA. These women were the highest to have hus-
bands with history of genital infection, showed vaginal
discharge by examination, reported history of infection
and higher sexual activity. HPV infection seemed to be
more among women whose husbands ever had another
wife or travelled before. In addition, one fourth of
unskilled workers had husbands who ever travelled before
or married another wife. In spite that the majority of
women had married once, 15% of unskilled workers had
married more than once. It is clear that the marital/sexual
practices of unskilled workers were the determinants of
their higher susceptibility to HPV and CIN. The socio-eco-
nomic characteristics of unskilled workers confirm previ-
ous studies where associations have been found between
low socioeconomic status [1,28,26], multiple sexual part-
ners [56-59] and cacx. Another risk factor, smoking, is
added to unskilled workers, as 83% of them were exposed
to smoking at home and work. Higher prevalence for
high-risk HPV types was significantly associated with cig-
arette smokers [60]. Steroid contraception has been pos-
tulated to be one mechanism whereby HPV exerts its
oncogenic effect on cervical tissue especially among long-
LCNK SCC, A- Fibres cells (arrow) and koilocytes (arrow head), Pap stain, × 400 Figure 5
LCNK SCC, A- Fibres cells (arrow) and koilocytes (arrow head), Pap stain, × 400. B- Marked nuclear pleomorphism and 
hyperchromasia and heavy neutrophilic infiltrate, Pap stain, × 400. C- Corresponding biopsy: islands of neoplastic cells sur-
rounded by heavy neutrophilic infiltrate, H&E, ×10
A- AGCUS favoring a neoplastic process, Pap stain, × 400 Figure 4
A- AGCUS favoring a neoplastic process, Pap stain, × 400. B- AIS, H&E staining, ×20.Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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term users [61], a point concordant with the present
study, mostly noted in one half of unskilled workers. The
prevalence of HPV in ASM and other abnormal biopsies
may be underestimated due to the fact that the HPV
probes used in the study do not cover all the high risk
types and include some low risk [47]. Additionally, nor-
mal tissues previously shown to harbour the virus
[22,46,47] were not tested due to financial limitations. A
third important point is the use of ISH technology, an
insensitive one compared to catalyzed signal amplified
colorimetric DNA ISH [62], to hybrid capture (HC) HPV
DNA assay [63-65] or polymerase chain reaction [66,67].
However, other studies showed that ISH HPV was more
predictive of biopsy histopathology in patients with
detectable cervical lesions than is HC HPV [68]. Further-
more, the sensitivity of ISH was comparable to that of
HC2, with significantly superior specificity, and was there-
fore thought to be an efficacious alternative to HC2 for
triaging patients with abnormal cervical cytology results
[69].
EGD, A- EGD, ISH, pan HPV probe, ×10 Figure 7
EGD, A- EGD, ISH, pan HPV probe, ×10. B- Higher power magnification showing variable degree of intensity with severe 
intensity in the middle zone, ×40.
CINIII, A- H&E, × 20 Figure 6
CINIII, A- H&E, × 20. B- HPV nucleic acid, ISH, pan HPV probe, × 20.Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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Our data on schistosomiaisis as risk factor for the develop-
ment of cacx confirm previous studies in Egypt [8,10] and
elsewhere [25]. However, T. vaginalis previously impli-
cated to have direct relation to cacx in the Egyptian popu-
lation [11] were not established in the actual work.
Moreover, early marriage or early sexual relations, was not
significantly associated with HPV as Egyptian women start
sexual relations with marriage. Other studies confirmed
that women who have their first intercourse at an early age
are at high risk for HPV infection and cacx [56,57,70].
Being uncircumcised male was found to be a high risk fac-
tor [59], which was not evaluated due to universality of
male circumcision among Egyptian men both Moslem
and Christians.
The study is limited by the fact that it covers a single
period and had no opportunity to examine trends over
time. Three obstacles reduced the number of satisfactory
smears, noted mostly at the beginning of the study, imply-
ing the importance of training. These were, smears not
interesting the squamo-columnar junction, inadequate
fixation and hemorrhagic smears resulting from traumati-
sation of the mucosa by the cytobrush. Inadequate biop-
sies were encountered whenever they were performed in
health units using portable colposcope. In addition,
women of higher socioeconomic group refusal to partici-
pate may have led to missing the chance to describe the
pattern of cervical lesions among this group. The drop out
of women for CGB was due to their refusal to participate
in spite of counselling. Concerning HPVs ISH, two points
should be discussed. The first was fixation more than 24
hours in UE specimens, a point that may explain the neg-
ativity for all HPVs probes even with the presence of frank
HPVs in biopsies. The second was the limited number of
tested probes compared to the known HPVs subtypes.
Cultural sensitivity for sexual relationships in the Egyp-
tian community in general and among women specifi-
cally, made it difficult to get detailed information even
Table 6: Prevalence of cervical lesions in the Egyptian population (n = 5453)
Cervical lesions Freq. %
CINI 111 2.04
CIN I+EGG 18 0.30
CINII 13 0.24
CIN II+EGG 2 0.03
CINIII 7 0.13
CINIII + EGD 1 0.02
EGD 12 0.22
AIS 1 0.02
SCC 1 0.02
Total 166 3.04
LCNK SCC A-, H&E, ×20 Figure 8
LCNK SCC A-, H&E, ×20. B- HPV nucleic acid in almost all the cells. ISH, pan HPV probe, × 20Infectious Agents and Cancer 2007, 2:12 http://www.infectagentscancer.com/content/2/1/12
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with using probing questions for assessing sexually trans-
mitted infections.
In conclusion, this study is the first one at a national level
describing the characteristics of women with cervical epi-
thelial abnormalities. They were mostly of middle
income, married, with three and more children, mostly
uneducated and not working. The awareness of the Egyp-
tian women by risk factors or symptoms of different
reproductive health problems are extremely low. Preva-
lence of CIN and invasive lesions was 3.1% and 0.04%,
while the prevalence of HPVs was 2.6% and was positive
in 94.3% of cervical lesions confirming that it is the main
causing agent. The study recommends introducing cacx
screening for all women at least once every 10 years for
women with normal cytological findings, and yearly for
three successive years for inflammatory changes. CGB
should be performed to all EA to avoid losing patients and
subsequently tumor progression. In addition, raising
awareness of Egyptian women on reproductive health and
risk factors of cacx through specially designed health com-
munication programs is mandatory.
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